Optimization of Production of Recombinant Adeno-Associated Virus Serotype 9

Issa S.S., Shaimardanova A.A., Solovyeva V.V., Rizvanov A.A. 2023. Various AAV serotypes and their applications in gene therapy: An overview. Cells. 12, 785.

CAS  PubMed  PubMed Central  Google Scholar 

Wang D., Tai P.W.L., Gao G. 2019. Adeno-associated virus vector as a platform for gene therapy delivery. Nat. Rev. Drug Discovery. 18, 358‒378.

CAS  PubMed  Google Scholar 

McCarty D.M. 2008. Self-complementary AAV vectors; advances and applications. Mol. Ther. 16, 1648‒1656.

CAS  PubMed  Google Scholar 

Lunev E., Karan A., Egorova T., Bardina M. 2022. Adeno-associated viruses for modeling neurological diseases in animals: Achievements and prospects. Biomedicines. 10, 1140.

CAS  PubMed  PubMed Central  Google Scholar 

Li C., Samulski R.J. 2020. Engineering adeno-associated virus vectors for gene therapy. Nat. Rev. Genet. 21, 255‒272.

CAS  PubMed  Google Scholar 

Brommel C.M., Cooney A.L., Sinn P.L. 2020. Adeno-associated virus-based gene therapy for lifelong correction of genetic disease. Hum. Gene Ther. 31, 985‒995.

CAS  PubMed  PubMed Central  Google Scholar 

Pupo A., Fernández A., Low S.H., François A., Suárez-Amarán L., Samulski R.J. 2022. AAV vectors: The Rubik’s cube of human gene therapy. Mol. Ther. 30, 3515‒3541.

CAS  PubMed  PubMed Central  Google Scholar 

Wang J.H., Gessler D., Zhan W., Gallagher L., Gao G. 2024. Adeno-associated virus as a delivery vector for gene therapy of human diseases. Signal Transduction Target Ther. 9, 78.

CAS  Google Scholar 

Ayuso E, Mingozzi F, Bosch F. 2010. Production, purification and characterization of adeno-associated vectors. Curr. Gene Ther. 10, 423‒436.

CAS  PubMed  Google Scholar 

Guan J.S., Chen K., Si Y., Kim T., Zhou Z., Kim S., Zhou L., Liu X.M. 2022. Process improvement of adeno-associated virus (AAV) production. Front. Chem. Eng. 4, 830421.

PubMed  PubMed Central  Google Scholar 

Kimura T., Ferran B., Tsukahara Y., Shang Q., Desai S., Fedoce A., Pimentel D.R., Luptak I., Adachi T., Ido Y., Matsui R., Bachschmid M.M. 2019. Production of adeno-associated virus vectors for in vitro and in vivo applications. Sci. Rep. 9, 13601.

PubMed  PubMed Central  Google Scholar 

Vorobyev P.O., Kochetkov D.V., Vasilenko K.V., Lipatova A.V. 2022. Comparative efficiency of accessible transfection methods in model cell lines for biotechnological applications. Bull. RSMU. 3, 11–18. https://doi.org/10.24075/brsmu.2022.031

Article  Google Scholar 

Zhao H., Lee K.J., Daris M., Lin Y., Wolfe T., Sheng J., Plewa C., Wang S., Meisen W.H. 2020. Creation of a high-yield AAV vector production platform in suspension cells using a design-of-experiment approach. Mol. Ther. Methods Clin. Dev. 18, 312‒320.

CAS  PubMed  PubMed Central  Google Scholar 

Aurnhammer C., Haase M., Muether N., Hausl M., Rauschhuber C., Huber I., Nitschko H., Busch U., Sing A., Ehrhardt A., Baiker A. 2012. Universal real-time PCR for the detection and quantification of adeno-associated virus serotype 2-derived inverted terminal repeat sequences. Hum. Gene Ther. Methods. 23, 18‒28.

CAS  PubMed  Google Scholar 

Bennett A., Mietzsch M., Agbandje-McKenna M. 2017. Understanding capsid assembly and genome packaging for adeno-associated viruses. Future Virol. 12, 283‒297.

CAS  PubMed  PubMed Central  Google Scholar 

Guan J.S., Chen K., Si Y., Kim T., Zhou Z., Kim S., Zhou L., Liu X.M. 2022. Process improvement of adeno-associated virus (AAV) production. Front. Chem. Eng. 4, 830421.

PubMed  PubMed Central  Google Scholar 

Ohba K., Mizukami H. 2023. Protocol for producing an adeno-associated virus vector by controlling capsid expression timing. STAR Protoc. 4, 102542.

CAS  PubMed  PubMed Central  Google Scholar 

Yang J., Zhou W., Zhang Y., Zidon T., Ritchie T., Engelhardt J.F. 1999. Concatamerization of adeno-associated virus circular genomes occurs through intermolecular recombination. J. Virol. 73, 9468‒9477.

CAS  PubMed  PubMed Central  Google Scholar 

Grieger J.C., Soltys S.M., Samulski R.J. 2016. Production of recombinant adeno-associated virus vectors using suspension HEK293 cells and continuous harvest of vector from the culture media for GMP FIX and FLT1 clinical vector. Mol. Ther. 24, 287‒297.

CAS  PubMed  Google Scholar 

Chaudhry M.A., Vitalis T.Z., Bowen B.D., Piret J.M. 2008. Basal medium composition and serum or serum replacement concentration influences on the maintenance of murine embryonic stem cells. Cytotechnology. 58, 173‒179.

PubMed  PubMed Central  Google Scholar 

Comments (0)

No login
gif